Suppr超能文献

文拉法辛剂量依赖性逆转 5-HT 耗竭诱导的空间工作和物体识别记忆缺陷:5-HT1A 受体激动作用和 5-HT3 受体拮抗作用的潜在作用。

Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism.

机构信息

Lundbeck Research USA, Inc., 215 College Road, 07652 Paramus, NJ, United States.

Lundbeck Research USA, Inc., 215 College Road, 07652 Paramus, NJ, United States.

出版信息

Eur Neuropsychopharmacol. 2014 Jan;24(1):160-71. doi: 10.1016/j.euroneuro.2013.07.001. Epub 2013 Aug 2.

Abstract

We previously reported that the investigational multimodal antidepressant, vortioxetine, reversed 5-HT depletion-induced memory deficits while escitalopram and duloxetine did not. The present report studied the effects of vortioxetine and the potential impact of its 5-HT1A receptor agonist and 5-HT3 receptor antagonist properties on 5-HT depletion-induced memory deficits. Recognition and spatial working memory were assessed in the object recognition (OR) and Y-maze spontaneous alternation (SA) tests, respectively. 5-HT depletion was induced in female Long-Evans rats using 4-cholro-DL-phenylalanine methyl ester HCl (PCPA) and receptor occupancies were determined by ex vivo autoradiography. Rats were acutely dosed with vortioxetine, ondansetron (5-HT3 receptor antagonist) or flesinoxan (5-HT1A receptor agonist). The effects of chronic vortioxetine administration on 5-HT depletion-induced memory deficits were also assessed. 5-HT depletion reliably impaired memory performance in both the tests. Vortioxetine reversed PCPA-induced memory deficits dose-dependently with a minimal effective dose (MED) ≤0.1mg/kg (∼80% 5-HT3 receptor occupancy; OR) and ≤3.0mg/kg (5-HT1A, 5-HT1B, 5-HT3 receptor occupancy: ∼15%, 60%, 95%) in SA. Ondansetron exhibited a MED ≤3.0μg/kg (∼25% 5-HT3 receptor occupancy; OR), but was inactive in the SA test. Flesinoxan had a MED ≤1.0mg/kg (∼25% 5-HT1A receptor occupancy; SA); only 1.0mg/kg ameliorated deficits in the NOR. Chronic p.o. vortioxetine administration significantly improved memory performance in OR and occupied 95%, 66%, and 9.5% of 5-HT3, 5-HT1B, and 5-HT1A receptors, respectively. Vortioxetine's effects on SA performance may involve 5-HT1A receptor agonism, but not 5-HT3 receptor antagonism, whereas the effects on OR performance may involve 5-HT3 receptor antagonism and 5-HT1A receptor agonism.

摘要

我们之前曾报道过,研究性多模式抗抑郁药文拉法辛能逆转 5-HT 耗竭诱导的记忆缺陷,而艾司西酞普兰和度洛西汀则不能。本报告研究了文拉法辛的作用及其作为 5-HT1A 受体激动剂和 5-HT3 受体拮抗剂的潜在影响对 5-HT 耗竭诱导的记忆缺陷的影响。通过物体识别(OR)和 Y 迷宫自发交替(SA)测试分别评估识别和空间工作记忆。使用 4-氯-DL-苯丙氨酸甲酯盐酸盐(PCPA)诱导雌性长耳大仓鼠的 5-HT 耗竭,并通过离体放射自显影术测定受体占有率。大鼠急性给予文拉法辛、昂丹司琼(5-HT3 受体拮抗剂)或 flesinoxan(5-HT1A 受体激动剂)。还评估了慢性文拉法辛给药对 5-HT 耗竭诱导的记忆缺陷的影响。5-HT 耗竭可靠地损害了两种测试中的记忆表现。文拉法辛以剂量依赖性方式逆转 PCPA 诱导的记忆缺陷,最小有效剂量(MED)≤0.1mg/kg(约 80%5-HT3 受体占有率;OR)和≤3.0mg/kg(5-HT1A、5-HT1B、5-HT3 受体占有率:约 15%、60%、95%)在 SA。昂丹司琼表现出 MED≤3.0μg/kg(约 25%5-HT3 受体占有率;OR),但在 SA 试验中无效。fleinoxan 的 MED≤1.0mg/kg(约 25%5-HT1A 受体占有率;SA);只有 1.0mg/kg 改善了 NOR 中的缺陷。慢性口服文拉法辛给药显著改善了 OR 中的记忆表现,分别占据了 5-HT3、5-HT1B 和 5-HT1A 受体的 95%、66%和 9.5%。文拉法辛对 SA 表现的影响可能涉及 5-HT1A 受体激动作用,但不涉及 5-HT3 受体拮抗作用,而对 OR 表现的影响可能涉及 5-HT3 受体拮抗作用和 5-HT1A 受体激动作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验